UCBJY : Summary for UCB ADR - Yahoo Finance

U.S. Markets open in 8 hrs 32 mins

UCB SA (UCBJY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
36.01-0.16 (-0.44%)
At close: 2:33PM EST
People also watch
TKPYYMKGAYDSNKYUMICYESALY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close36.17
Open35.96
Bid0.00 x
Ask0.00 x
Day's Range35.96 - 36.01
52 Week Range29.20 - 41.60
Volume1,609
Avg. Volume1,185
Market Cap6.78B
Beta0.41
PE Ratio (TTM)19.43
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.63 (1.75%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 months ago

    Amgen And UCB Announce Submission Of Application For Investigational Osteoporosis Medication Romosozumab In Japan

    THOUSAND OAKS, Calif. and BRUSSELS, Dec. 19, 2016 /PRNewswire/ -- Amgen (AMGN) and UCB (Euronext Brussels: UCB) today announced that an application seeking marketing approval of romosozumab for the treatment of osteoporosis for those at high risk of fracture has been submitted for review to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. Amgen and UCB are co-developing romosozumab worldwide, with development in Japan being led by Amgen Astellas BioPharma (AABP) K.K., a joint venture between Amgen and Astellas Pharma Inc., a pharmaceutical company headquartered in Tokyo.

  • PR Newswire3 months ago

    Results From Phase 3 BRIDGE Study Show Romosozumab Significantly Increases Bone Mineral Density In Men With Osteoporosis

    THOUSAND OAKS, Calif. and BRUSSELS, Nov. 12, 2016 /PRNewswire/ -- Amgen (AMGN) and UCB (Euronext Brussels: UCB) today announced results from the Phase 3 BRIDGE study showing that in men with osteoporosis, the investigational agent romosozumab resulted in significant bone mineral density (BMD) gains at the lumbar spine, total hip and femoral neck compared to placebo at six and 12 months. Although more common in women, osteoporosis is also a serious health issue for men.

  • PR Newswire3 months ago

    UCB Family Epilepsy Scholarship Program™ Announces 2016 Recipients

    ATLANTA, Nov. 10, 2016 /PRNewswire/ -- UCB, Inc. today announced 40 recipients of the 2016 UCB Family Epilepsy Scholarship, recognizing outstanding individuals affected by epilepsy who are pursuing higher ...